Summary
In 15 insulin dependent diabetics (IDDM), treated with human monocomponent insulin, the absorption of Actrapid HM mixed with Ultratard HM was evaluated. Thirty U of Ultratard HM and 10 U of Actrapid HM were injected separately or together immediately after mixing. Free insulin and plasma glucose (PG) were measured four hours after the administration. Free insulin levels were significantly higher after 15 (2p<0.01), 60 (2p<0.05) and 90 min (2p<0.005) when the two insulins were injected separately. PG values were significantly lower (2p<0.05) (7.63±4.06 mmol/1) at 120 min when the two insulins were injected separately compared to the mixture (9.45±4.22 mmol/l). In conclusion, mixing Ultratard HM and Actrapid HM 3:1, we observed a decrease of early Actrapid absorption and a slower lowering of PG values.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Berger M., Cüppers H. J., Hegner H., Jörgens V., Berchtold P.: Absorption kinetics and biologic effects of subcutaneously injected insulin preparations — Diabet. Care5, 77, 1982.
Deckert T.: Intermediate acting insulin preparations: NPH and Lente — Diabet. Care3, 623, 1980.
Francis A. J., Hanning I., Alberti K. G. M. M.: The effect of mixing human soluble and human crystalline zinc-suspension insulin: plasma insulin and blood glucose profiles after subcutaneous injection — Diabet. Med.2, 177, 1985.
Galloway J. A., Spradlin C. T., Jackson R. L., Otto D. C., Bechtel L. D.: Mixtures of intermediate-acting insulin (NPH and Lente) with regular insulin: an update. In:Skiler J. S. (Ed.). Insulin update: 1982. Proceedings of a Symposium held in Key Biscayne/FL, December 7–9, 1981. Excerpta Medica, Princeton/NJ, 1982; p. 111.
Galloway J. A., Spradlin C. T., Nelson R. L., Wentworth S. M., Davidson J. A., Swarner J. L.: Factor influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures — Diabet. Care4, 366, 1981.
Heine R. J., Bilo H. J. G., Fonk T., van der Veen E. A., van der Meer J.: Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins — Diabetologia27, 558, 1984.
Holdman R. R., Steemson J., Darling P., Revees W.G., Turner R. C.: Human ultralente insulin — Brit. med. J.288, 665, 1984.
Kemmer F. W., Sonnenberg G., Cüppers H. J., Berger M.: Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin — Diabet. Care5 (Suppl. 2), 23, 1982.
Lunetta M., Di Mauro M., Crimi S., Palermo F., Mughini L.: The effect of mixing zinc-suspension and soluble semisynthetic human insulin on plasma insulin and blood glucose profiles after subcutaneous injection — IRCS med. Sci.14, 655, 1986.
Lunetta M., Di Mauro M., La Bella G., Buttiglieri R., Sudano L.: Miscibility of biosynthetic intermediate-acting protamine insulin with short-acting insulin — Med. Sci. Res.15, 155, 1987.
Mühlhauser I., Boerman C., Tsotsalas M., Berger M.: Miscibility of human and bovine ultralente insulin with soluble insulin — Brit. med. J.289, 1656, 1984.
Skyler J. S.: Type I diabetes… regimens, targets, and caveats (Editorial) — Diabet. Care5, 547, 1982.
Tsotsalas M., Mühlhauser I.: Miscibility of human lente insulin with soluble insulin — Diabetologia28, 252, 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lunetta, M., Mauro, M.d., Crimi, S. et al. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients. Acta diabet. lat 25, 263–269 (1988). https://doi.org/10.1007/BF02624822
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624822